India's Ranbaxy gets WHO approval for AIDS drug
MUMBAI |
MUMBAI Nov 12 (Reuters) - Ranbaxy Laboratories (RANB.BO), India's top drug maker by sales, said on Thursday it received the World Health Organization pre-qualification for its Indinavir anti-retroviral AIDS drug.
Pre-qualification acts as a guide to United Nations agencies and countries that select suppliers for drugs. (Reporting by Pratish Narayanan; Editing by John Mair)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters